Skip to main content

Multiple Myeloma Learning Library

New & Trending

Beth Faiman, CNP, PhD, Cleveland Clinic
Videos
07/21/2025
Beth Faiman, CNP, PhD
Beth Faiman, CNP, PhD, discusses treatment decision-making for a patient with multiple myeloma whose disease relapsed through several lines of therapy.
Beth Faiman, CNP, PhD, discusses treatment decision-making for a patient with multiple myeloma whose disease relapsed through several lines of therapy.
Beth Faiman, CNP, PhD, discusses...
07/21/2025
APP Institute Oncology
Beth Faiman, CNP, PhD, Cleveland Clinic
Videos
07/21/2025
Beth Faiman, CNP, PhD
Beth Faiman, CNP, PhD, discusses treatment decision-making for a patient with symptomatic relapsed multiple myeloma.
Beth Faiman, CNP, PhD, discusses treatment decision-making for a patient with symptomatic relapsed multiple myeloma.
Beth Faiman, CNP, PhD, discusses...
07/21/2025
APP Institute Oncology
Beth Faiman & Donna Catamero
Clinical Pearls
07/11/2025
Beth Faiman, CNP, PhD; Donna Catamero, NP
Beth Faiman, CNP, PhD, and Donna Catamero, NP, discuss updates in multiple myeloma from the 2025 ASCO Annual Meeting and EHA Congress, highlighting pivotal studies exploring the use of bispecifics in earlier lines of treatment and emerging...
Beth Faiman, CNP, PhD, and Donna Catamero, NP, discuss updates in multiple myeloma from the 2025 ASCO Annual Meeting and EHA Congress, highlighting pivotal studies exploring the use of bispecifics in earlier lines of treatment and emerging...
Beth Faiman, CNP, PhD, and Donna...
07/11/2025
APP Institute Oncology
Beth Faiman & Donna Catamero
Clinical Pearls
07/11/2025
Beth Faiman, CNP, PhD; Donna Catamero, NP
Beth Faiman, CNP, PhD, and Donna Catamero, NP, discuss bispecific antibody therapy for multiple myeloma and important considerations for patient selection and side effect management, highlighting recent data and real-world applications.
Beth Faiman, CNP, PhD, and Donna Catamero, NP, discuss bispecific antibody therapy for multiple myeloma and important considerations for patient selection and side effect management, highlighting recent data and real-world applications.
Beth Faiman, CNP, PhD, and Donna...
07/11/2025
APP Institute Oncology
Caroline Schinke, MD
Oncology Advances
08/09/2024
Caroline Schinke, MD, Myeloma Center at the University of Arkansas, speaks about the long-term efficacy and safety results from the MonumenTAL-1 trials on talquetamab treatment among patients with MM.
Caroline Schinke, MD, Myeloma Center at the University of Arkansas, speaks about the long-term efficacy and safety results from the MonumenTAL-1 trials on talquetamab treatment among patients with MM.
Caroline Schinke, MD, Myeloma...
08/09/2024
APP Institute Oncology
Samantha Shenoy
Videos
05/09/2024
Samantha Shenoy, NP, discusses considerations for nurses and advanced practitioners managing patients with relapsed/refractory multiple myeloma experiencing oral toxicities after treatment with talquetamab.
Samantha Shenoy, NP, discusses considerations for nurses and advanced practitioners managing patients with relapsed/refractory multiple myeloma experiencing oral toxicities after treatment with talquetamab.
Samantha Shenoy, NP, discusses...
05/09/2024
APP Institute Oncology
Beth Finley-Oliver and Rachid Baz, Moffitt Cancer Center
Clinical Pearls
11/27/2023
Elizabeth Finley-Oliver, ARNP, MSN; Rachid Baz, MD
Elizabeth Finley-Oliver, MSN, ARNP, AGNP-BC, and Rachid Baz, MD, discuss the treatment landscape for patients with multiple myeloma and how clinicians can individualize care while addressing patient needs.
Elizabeth Finley-Oliver, MSN, ARNP, AGNP-BC, and Rachid Baz, MD, discuss the treatment landscape for patients with multiple myeloma and how clinicians can individualize care while addressing patient needs.
Elizabeth Finley-Oliver, MSN,...
11/27/2023
APP Institute Oncology
Lorinda Coombs
APP Perspectives
11/17/2023
Lorinda Coombs, PhD, CNS, FNP-BC
Lorinda Coombs, PhD, CNS, FNP-BC, AOCNP, discusses results from a survey that inform patients and advanced practice provider perspectives on myeloma care.
Lorinda Coombs, PhD, CNS, FNP-BC, AOCNP, discusses results from a survey that inform patients and advanced practice provider perspectives on myeloma care.
Lorinda Coombs, PhD, CNS,...
11/17/2023
APP Institute Oncology

Clinical Pearls

APP Perspectives

Lorinda Coombs
APP Perspectives
11/17/2023
Lorinda Coombs, PhD, CNS, FNP-BC
Lorinda Coombs, PhD, CNS, FNP-BC, AOCNP, discusses results from a survey that inform patients and advanced practice provider perspectives on myeloma care.
Lorinda Coombs, PhD, CNS, FNP-BC, AOCNP, discusses results from a survey that inform patients and advanced practice provider perspectives on myeloma care.
Lorinda Coombs, PhD, CNS,...
11/17/2023
APP Institute Oncology
Lorinda Coombs
APP Perspectives
11/17/2023
Lorinda Coombs, PhD, CNS, FNP-BC
Lorinda Coombs, PhD, CNS, FNP-BC, AOCNP, discusses results from a survey that inform patients and advanced practice provider perspectives on myeloma care.
Lorinda Coombs, PhD, CNS, FNP-BC, AOCNP, discusses results from a survey that inform patients and advanced practice provider perspectives on myeloma care.
Lorinda Coombs, PhD, CNS,...
11/17/2023
APP Institute Oncology

Conference Coverage

Lorinda Coombs
APP Perspectives
11/17/2023
Lorinda Coombs, PhD, CNS, FNP-BC
Lorinda Coombs, PhD, CNS, FNP-BC, AOCNP, discusses results from a survey that inform patients and advanced practice provider perspectives on myeloma care.
Lorinda Coombs, PhD, CNS, FNP-BC, AOCNP, discusses results from a survey that inform patients and advanced practice provider perspectives on myeloma care.
Lorinda Coombs, PhD, CNS,...
11/17/2023
APP Institute Oncology
David Spigel, MD, Sarah Cannon Research Institute
Videos
06/16/2025
David Spigel, MD
David Spigel, MD, discusses the results of the AIM-HIGH trial to evaluating the predictive efficacy of a 14-gene expression profile in identifying stage Ia to IIa patients with non-squamous NSCLC who benefit from adjuvant therapy.
David Spigel, MD, discusses the results of the AIM-HIGH trial to evaluating the predictive efficacy of a 14-gene expression profile in identifying stage Ia to IIa patients with non-squamous NSCLC who benefit from adjuvant therapy.
David Spigel, MD, discusses the...
06/16/2025
APP Institute Oncology
Patrick Forde, MBBCh
Videos
06/05/2025
Patrick Forde, MD
Patrick Forde, MBBCh, shares insights on the long-term overall survival benefit demonstrated by neoadjuvant nivolumab plus chemotherapy among patients with resectable non-small cell lung cancer, as seen in the CheckMate 816 trial.
Patrick Forde, MBBCh, shares insights on the long-term overall survival benefit demonstrated by neoadjuvant nivolumab plus chemotherapy among patients with resectable non-small cell lung cancer, as seen in the CheckMate 816 trial.
Patrick Forde, MBBCh, shares...
06/05/2025
APP Institute Oncology
Phuong Vo, MSN, RN, OCN, MEDSURG-BC
Videos
05/20/2025
Phuong Vo, MSN, RN, OCN, MEDSURG-BC
At the 2025 ONS Congress, Phuong Vo, MSN, RN, OCN, MEDSURG-BC shares the development and impact of a high-fidelity simulation training for hypersensitivity reaction preparedness among newly hired infusion nurses.
At the 2025 ONS Congress, Phuong Vo, MSN, RN, OCN, MEDSURG-BC shares the development and impact of a high-fidelity simulation training for hypersensitivity reaction preparedness among newly hired infusion nurses.
At the 2025 ONS Congress, Phuong...
05/20/2025
APP Institute Oncology
Fabienne Gaillard Ulysse, DNP, AOCNP, ANP-BC, FAAN
Conference Coverage
05/07/2025
Fabienne Gaillard Ulysse, DNP, AOCNP, ANP-BC, FAAN shares the impact of a community education program designed to increase cancer screening rates among New York residents.
Fabienne Gaillard Ulysse, DNP, AOCNP, ANP-BC, FAAN shares the impact of a community education program designed to increase cancer screening rates among New York residents.
Fabienne Gaillard Ulysse, DNP,...
05/07/2025
APP Institute Oncology
Jennifer Stephens MA, PhD, RN, OCN, CCNE
Conference Coverage
05/07/2025
Jennifer Stephens, MA, PhD, RN, OCN, CCNE
Jennifer Stephens MA, PhD, RN, OCN, CCNE, discusses results from a netnographic study which explored the phenomenon of “cancer ghosting.”
Jennifer Stephens MA, PhD, RN, OCN, CCNE, discusses results from a netnographic study which explored the phenomenon of “cancer ghosting.”
Jennifer Stephens MA, PhD, RN,...
05/07/2025
APP Institute Oncology
Nicole Ferreira, MSN, RN, NPD-BC, BMTCN, OCN
Videos
05/05/2025
At the 2025 ONS Congress, Nicole Ferreira, MSN, RN, NPD-BC, BMTCN, OCN shares the development of an oncology fellowship program aimed to improve specialized practitioner education and competence as well as decrease practice turnover.
At the 2025 ONS Congress, Nicole Ferreira, MSN, RN, NPD-BC, BMTCN, OCN shares the development of an oncology fellowship program aimed to improve specialized practitioner education and competence as well as decrease practice turnover.
At the 2025 ONS Congress, Nicole...
05/05/2025
APP Institute Oncology
Robert Bennett, PhD, RN, PPCNP-BC, CPNP-AC
Conference Coverage
05/01/2025
Robert Bennett, PhD, PPCNP-BC, CPNP-AC
Robert Bennett, PhD, RN, PPCNP-BC, CPNP-AC, discusses a study aiming to determine symbols of hope as described by Hispanic adolescent and young adult survivors of cancer.
Robert Bennett, PhD, RN, PPCNP-BC, CPNP-AC, discusses a study aiming to determine symbols of hope as described by Hispanic adolescent and young adult survivors of cancer.
Robert Bennett, PhD, RN,...
05/01/2025
APP Institute Oncology
Jamie Myers, PhD, RN, AOCNS, FAAN
Conference Coverage
05/01/2025
Jamie Myers, PhD, RN, AOCNS, FAAN
Jamie Myers, PhD, RN, AOCNS, FAAN, discusses the evaluation of a mobile digital application, MindCap, to assess the cognitive function of cancer survivors.
Jamie Myers, PhD, RN, AOCNS, FAAN, discusses the evaluation of a mobile digital application, MindCap, to assess the cognitive function of cancer survivors.
Jamie Myers, PhD, RN, AOCNS,...
05/01/2025
APP Institute Oncology
Maureen O’Brien, CNS
Conference Coverage
05/01/2025
Maureen O'Brien, CNS
Maureen O’Brien, CNS, outlines the tobacco treatment training-oncology, a 2-day workshop that aims to provide oncology nurses with relevant skills for management tobacco use and tobacco dependence among patients.
Maureen O’Brien, CNS, outlines the tobacco treatment training-oncology, a 2-day workshop that aims to provide oncology nurses with relevant skills for management tobacco use and tobacco dependence among patients.
Maureen O’Brien, CNS, outlines...
05/01/2025
APP Institute Oncology
Deborah Christensen, MSN, APRN, AOCNS
Videos
04/30/2025
Deborah Christensen, MSN, APRN
At the Oncology Nursing Society Congress, Deborah Christensen, MSN, APRN, AOCNS shares the development of a virtual oncology navigation model designed to improve patient access to cancer care.
At the Oncology Nursing Society Congress, Deborah Christensen, MSN, APRN, AOCNS shares the development of a virtual oncology navigation model designed to improve patient access to cancer care.
At the Oncology Nursing Society...
04/30/2025
APP Institute Oncology